A total of 22 mutations are observed in the 1976 bp-long promoter region of PRSS3. This is four times more mutations than expected under the null model, and they occur in 13 samples from seven different cancer types (q = 1.1 × 10−2, ncdDetect). Here, PRSS3 is linked to cancer.